Survival of melanoma patients treated with novel drugs: retrospective analysis of real-world data.

Purpose: Recently, several new drugs have been licensed for advanced melanoma therapy, significantly changing the therapeutic landscape. Ipilimumab and vemurafenib were the first drugs that demonstrated a survival benefit over the long-standing standard therapy with dacarbazine. However, the comparative efficacy of these novel drugs has not been properly assessed yet.

[Coordinated care after myocardial infarction. The statement of the Polish Cardiac Society and the Agency for Health Technology Assessment and Tariff System].

The in-hospital mortality following myocardial infarction has decreased substantially over the last two decades in Poland. However, according to the available evidence approximately every 10th patient discharged after myocardial infarction (MI) dies during next 12 months. We identified the most important barriers (e.

[Evaluation of self-measurement of blood pressure im ambulatory monitoring of hypertension therapy].

Objectives: The aim of this study was to compare the usefulness and credibility of ambulatory self-measurement of blood pressure (SMBP) by hypertensive patients to automatic ambulatory blood pressure monitoring (ABPM).

Methods: The study was performed in 51 patients with primary hypertension (19 F, 32 M), aged 25-67 y divided into 3 groups: I-without treatment (n = 13), II-receiving monotherapy (n = 17) and III-treated at least with 2 hypotensive drugs (n = 21). For three consecutive days, patients measured their systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) three times a day at 2 minute intervals during the following periods 06:00-08:00, 15:00-17:00 and 20:00-22:00.

[8 cases of thrombotic thrombocytopenic purpura].

Eight cases of the thrombocytopenic thrombosis are presented. Etiological factors, prognosis, and actual therapy are discussed. An emphasis is on the significance of freshly frozen plasma administration in the treatment of this disease.

[Results of treating acute myeloblastic leukemia in patients over 60 years of age].

An efficiency of the acute myeloblastic leukemia therapy has been assessed in 79 patients aged over 60 years. Twenty six patients out of this group have been treated with usual or reduced doses of doxorubicin and cytarabine (ADR-Ara-C) 35--low doses of cytarabine (LD Ara-C), 11-6-mercaptopurine (6 MP), and 7 patients died before chemotherapy. Complete remission in group treated with ADR-Ara-C was achieved in 23% of patients while partial remission in 42%.

The coexistence of chronic lymphocytic leukaemia and polycythaemia vera terminating in acute myeloid leukaemia.

A 67-year-old man with the coexistence of CLL and PV converted after 4 years to AML is described. This rare simultaneous occurrence of both chronic lymphoid and myeloid proliferations as well as nonlymphoblastic leukaemia developing in a patient with CLL is discussed in the light of literature data.